Background: Rocuronium has an onset of action more rapid than other non-depolarizing neuromuscular blocking agents, but it is unclear whether it and succinykholine give equivalent intubating conditions during rapid-sequence induction of anaesthesia. We performed this study to answer the question -are there clinically relevant differences between the use of rocuronium and succinylcholine to secure acceptable intubating conditions during rapid-sequence induction of anaesthesia with propofol? Methods: Anaesthesia was induced using propofol 2.5 mg/kg in 349 ASA physical status grade I-IV patients who were undergoing either elective or emergency surgery. Propofol was followed immediately by either rocuronium 0.6 or 1 mg/kg or succinylcholine 1.0 mg/kg (randomly selected). Fifty seconds after the end of muscle relaxant injection laryngoscopy was performed and intubating conditions were graded by an experienced anaesthetist blind to the muscle relaxant allocation. This study design was selected so that a 10% difference in clinically
R
OCURONIUM has an onset of action more rapid than .other available non-depolarizing neuromuscular blocking agents. It is therefore probably the most appropriate choice as a non-depolarizing alternative to succinylcholine during rapid-sequence induction of anaesthesia. A number of studies have evaluated the equivalence of tracheal intubating conditions when rocuronium 0.6 mg/kg or succinylcholine were used at the start of anaesthesia, but all these studies have designs which could not demonstrate small but clinically relevant differences (1) (2) (3) (4) (5) (6) (7) (8) . In addition, most of these studies were not conducted during rapid-sequence induction of anaesthesia. If the anaesthesia were more established at tracheal intubation, compared with during a rapid-sequence induction, this might improve intubating conditions and mask potential differences between rocuronium and succinylcholine (1) (2) (3) (4) (5) . While many of the studies do not demonstrate any difference in the incidence of satisfactory intubating conditions between rocuronium and succinylcholine (1) (2) (3) (4) , others suggest that rocuronium 0.6 mg/kg does not give the same incidence of excellent intubating conditions as succinylcholine at 60 s (5, 6) , although only one of these studies was conducted during a rapid-sequence induction of anaesthesia (6) . These findings are supported by a report indicating that intubating conditions improve with rocuronium during rapid-sequence induction of anaesthesia if an opioid is given during the sequence (7) , and another that suggests intubating conditions are better with rocuronium if it is given before, compared with after, the intravenous anaesthetic (8) . These latter studies indicate that rocuronium 0.6 mg/kg does not give the best achievable incidence of satisfactory intubating conditions during rapid-sequence induction of anaesthesia. This suggestion is supported by the observation that complete neuromuscular block at the larynx is only seen with doses in excess of 1.0 mg/kg (9) .
One possible explanation for these cor\flicts in the literature is that these studies were performed in relatively small numbers of patients and may have lacked sensitivity. An alternative explanation is that adequate anaesthesia, particularly if it includes propofol, can contribute considerably to the quality of intubating conditions, and make the choice of neuromuscular blocking agent unimportant. This research addresses two questions as follows. Is neuromuscular blockade necessary during rapid-sequence induction of anaesthesia? and if it is necessary, are there clinically relevant differences in the incidence of acceptable intubating conditions with rocuronium and succinylcholine?
Methods
With the approval of the respective ethics committees and with written informed consent we studied patients undergoing surgery requiring endotracheal intubation. All patients were of ASA physical status I to V, in the age range 18-75 and weighed no more than 135% of the calculated ideal weight. We did not study pregnant patients or breast-feeding patients, patients with open eye injury, patients with conditions expected to alter the time course of neuromuscular block, patients taking anticonvulsant medication or patients in whom we anticipated difficulty with endotracheal intubation. Patients underwent rapid-sequence induction of anaesthesia using propofol with either rocuronium 0.6 or 1.0 mg/kg or succinylcholine 1.0 mg/kg.
Patients were brought to the operating room and were allocated to a muscle relaxant group. The allocation was carried out randomly, without replacement, and with concealment from the investigator performing the randomization; it was stratified for study centre and type of surgery (emergency or elective). In the operating room, we placed an intravenous cannula in a large forearm vein; where this was not possible we used a vein on the back of the hand. Oxygen was administered via an anaesthetic breathing circuit and face mask. After 150 s preoxygenation, cricoid pressure was applied and propofol 2.5 mg/kg was administered intravenously over 20 s followed immediately by the muscle relaxant. Laryngoscopy commenced 50 s after the end of muscle relaxant injection and was performed by an anaesthetist blind to the muscle relaxant group, the aim being to intubate the trachea 60 s after the end of muscle relaxant injection. Blinding was achieved by concealing the patient from the investigator until immediately before the laryngoscopy. Subsequent anaesthetic management was at the discretion of the clinician. After operation patients were visited within 24 h and screened for adverse events.
To determine whether neuromuscular block contributes to intubating conditions during rapid-sequence induction with propofol we studied two doses of rocuronium, 0.6 and 1.0 mg/kg, (ideally we might have included a placebo group, but ethical considerations prevented this because we wished to study patients with a genuine requirement for rapid-sequence induction of anaesthesia). For this part of the study the hypothesis to be tested was that distributions of intubating condition scores were different with two doses of rocuronium. We planned to study 56 patients in each group, allowing for 6 patients per group to be excluded from analysis. To minimize the total number of patients required we began the study with three groups: two groups receiving the two doses of rocuronium and an additional group receiving succinylcholine 1.0 mg/kg. After the comparison of the two doses of rocuronium we continued the study with just two groups, patients receiving succinylcholine or a single dose of rocuronium; that dose was to be 0.6 mg/kg unless the 1.0 mg/kg further improved intubating conditions. The hypothesis to be tested during this part of the study was that the probability of clinically acceptable intubating conditions would not differ between rocuronium and succinylcholine groups. We determined that a 10% difference in the probability of a clinically acceptable score was of borderline clinical relevance and calculated that to detect such a difference at the 5% significance level would require 260 patients, 130 with each muscle relaxant. To allow for patients to be subsequently excluded from analysis we decided to treat 280 patients. The predetermined minimum number of patients to be studied was therefore 336 (280 plus 56).
Intubating conditions were evaluated using six variables (10) . These related to jaw relaxation, perceived resistance to the laryngoscopy blade, position of the vocal cords, residual movement of the vocal cords, limb movement in reaction to intubation and coughing in response to intubation. Each of these variables was assigned a value from the list:-excellent, good and poor. The criteria for assigning values to each variable are set out in Table 1 . We assigned a single summary grade for intubating conditions to each patient according to the number of variables with each value. Intubating conditions were excellent if all variables were excellent. If all the variables were not excellent, then intubating conditions were good unless any variable was poor. If any variable was poor, theri intubating conditions were poor, and if the intubation attempt failed at 60 s intubating conditions were graded as failed. Excellent and good intubating conditions were considered clinically acceptable (10) . Table 1 Criteria used to attribute scores to each of six variables used in the evaluation of intubating condition (10 For the comparison of the two doses of rocvironium, the frequency distributions of the four possible intubating condition scores were compared between doses using the extended Mantel-Haenszel test. This is a variation of the x^ test which allows variability which can be accounted for on the basis of other known factors to be discounted; it is therefore more sensitive than a simple x^-We permitted variability attributable to study centre and type of operation (emergency or elective) to be taken into account. When this test indicated that there was a difference between the two rocuronium doses, we decided which dose was giving the better conditions by examining all possible 2X2 reductions of the distribution table. For the comparison of the chosen dose of rocuronium with succinylcholine, the probabilities of clinically acceptable intubating conditions were compared between the two treatments again using the extended Mantel-Haenszel test. All analyses were performed twice, once for all patients who were allocated a treatment and had at least one evaluation perfonned (the intention-to-treat analysis) and once including only those patients who were treated exactly according to the protocol (perprotocol analysis). The per-protocol results are presented vmless there are differences in substance between the two types of analysis.
Results
We studied 107 patients in the comparison of the two doses of rocuroruum, of whom 13 were excluded from the per-protocol analysis. The reasons for these exclusions were: -receiving the wrong treatment (3), intubation commencing late (2), incorrect dose (2), body weight greater than 135% of ideal (2), unanticipated anatomical difficulty with intubation (1), assessor unblinded (1), surgery cancelled before anaesthesia commenced (1) and essential data lost (1) . Demographic characteristics and the distribution of the intubating condition scores of the remairting patients are given in Table 2 . The distribution of intubating condition scores differed between dose groups (P<0.05). Further analysis revealed that the incidence of excellent intubating conditions was 40% and 67% with the 0.6 and 1.0 mg/kg doses, respectively (P<0.05). The second part of the study therefore continued with rocuronium 1.0 mg/kg.
For the comparison of rocuronium and succinylcholine we studied 349 patients, of whom 56 received rocuronium 0.6 mg/kg and were excluded from the drug comparison; there were 293 patients remaining who received rocuroruum 1.0 mg/kg or succinylcholine 1.0 mg/kg. A total of 24 patients were excluded for the following reasons: -body weight greater than 135% of ideal (7), incorrect dose (4), wrong treatment (3), surgery cancelled before anaesthesia commenced (3), assessor unblinded (2), unanticipated anatomical difficulty with intubation (4) and laryngoscope light failure (1). Demographic characteristics and the distri- Table 2 Demographic characteristics and the distribution of intubating conditions in the 94 patients studied according to the protocol for the comparison of rocuronium 0.6 with rocuronium 1.0 mg/kg. Values are mean (SD), n, or n (%). (23) 3 (2) 1 (1) bution of the intubating condition scores of the two groups are given in Table 3 . The proportion of patients with clinically acceptable intubating conditions was 93.2% and 97.1% for the rocuronium and succinylcholine groups, respectively. The difference between the groups (rocuroruum minus succinylcholine) was therefore -3.9% (95% confidence interval -9.7% to 1.9%); the equivalent results for the intention-to-treat analysis were -3.8% (-10% to 2.4%).
Discussion
The rationale behind rapid-sequence induction of anaesthesia is to create an environment in which the trachea can be intubated as quickly and with as little difficulty as possible. It is used where there is a greater than usual risk of regurgitation and aspiration of stomach contents. The clirucal conditions occurring at the time of the intubation attempt are therefore of great importance. We have studied the incidence of clinically acceptable intubating conditions occurring with rocuronium 1.0 mg/kg or succinylcholine 1.0 mg/kg in a rapid-sequence induction of anaesthesia with propofol. We studied sufficient patients to be capable of detecting a difference in this incidence of 10%. We observed that the incidence of clinically acceptable intubating conditions was 3.9% less with rocuronium than with succinylcholine. This is not a clinically relevant difference. The 95% confidence interval for this difference was -9.7% to 1.9%, implying that we are 95% certain that the true difference falls within these limits. These findings satisfy the requirements necessary to demoristrate equivalence and, subject to the assumption that a 10% difference really is not clinically relevant, we can conclude that the two treatments are equivalent. During a rapid-sequence induction of anaesthesia the drugs used to produce anaesthesia and those used to produce muscle relaxation interact together to produce the intubating conditions. This interaction creates a very complex array of possibilities because of the number of agents and doses we might choose to use. This complex array of possibilities can raise additional questions which might limit our ability to draw conclusions. We will examine two of these additional questions in the following paragraphs.
How can we be sure that the muscle relaxant is necessary? Intubation has frequently been performed without muscle relaxation after induction of anaesthesia with propofol (11, 12) and the quality of the intubating conditions may be comparable with those after succinylcholine (12) . If our two treatment groups manifest similar intubating conditions, then can we be certain that muscle relaxation is contributing at all? To answer this question, ideally we would have studied also a group receiving no muscle relaxant, a placebo control group. But we wished to include patients with a genuine need for rapid-sequence induction and we considered it unwise to exclude the muscle relaxant altogether in such patients. Rocuronium 0.6 mg/kg is a widely used dose for intubation where rapid-sequence induction is not required, and it has been used in preliirunary studies of rocuroruum for rapid intubation (1-6). There are indicatioris, however, that its action may not be very profound in all patients. For instance, there have been suggestions that an opioid can further improve intubating conditions with rocuroruum 0.6 mg/kg dviring rapid-sequence induction of anaesthesia (7), and that intubating conditions can be improved if rocuronium 0.6 mg/kg is given before, compared with after, the intravenous anaesthetic (8) . In addition, we have observed the peak effect at the laryngeal muscles of rocuronium 0.6 mg/kg to be substantially less than complete block in most patients (9) . During this study we observed that increasing the dose of rocuronium from 0.6 to 1.0 mg/kg improves intubating conditions; this would not be so if rocuronium was not making some contribution to those conditions. We infer that muscle relaxation is desirable during rapid-sequence induction. We also infer that rocuronium 1.0 mg/kg contributes additional benefit over a dose of 0.6 mg/kg and is a more appropriate dose for rapid-sequence induction of anaesthesia. The incidence of clinically acceptable Lntubating conditions in the 48 per-protocol patients who received rocuronium 0.6 mg/kg was 77%; this compares with the incidences of more than 90% observed with both the other two groups during the remainder of the study.
Can we be sure that other drugs given during the induction did not create a high incidence of acceptable intubating conditions? Many agents given at the start of anaesthesia might contribute to the quality of the intubating conditions, particularly the opioids (11). We did not give an opioid in the induction sequence because not all anaesthetists will do so. Addition of an opioid (or any other drugs contributing to a greater depth of anaesthesia) could only be expected to further improve intubating conditions. This study therefore represents a very severe test of rocuronium's ability to ensure adequate intubating conditions. However, we must be cautious in our interpretation and limit our conclusions regarding the muscle relaxants to occasions where this particular induction sequence is used. Other induction sequences should be evaluated in additional studies.
The results presented here are in keeping with much of the literature on intubating conditions after either rocuronium or succinylcholine. Although some of the early studies did not detect differences between rocuronium 0.6 mg/kg and succinylcholine 1.0 mg/kg, these studies were preliminary studies, not conducted during rapid-sequence induction of anaesthesia and performed in relatively small numbers of patients (1) (2) (3) (4) . The early indications that rocuronium 0.6 mg/kg is not equivalent to succinylcholine during rapid-sequence induction of anaesthesia (6) (7) (8) are confirmed by this study. Rocuronium 0.6 mg/kg has only a modest peak effect at the laryngeal muscle (9) , and it is not surprising that intubating conditions were further improved by increasing the dose. Doses in excess of 1.0 mg/kg might further increase the proportion of patients developing complete block at the larynx (9), but the results of this study demonstrate that such increases are unlikely to be clinically important.
We conclude from this study that rocuronium 1.0 mg/kg given along with propofol in a rapid-sequence induction of anaesthesia contributes to the quality of the intubating conditions, and is clinically equivalent to succinylcholine 1.0 mg/kg for this purpose. Its duration of action will be greatly in excess of that of succinylcholine, and the clinician must decide in each case if the duration of action is an important determinant of his choice of muscle relaxant.
